or
forgot password

    • cancer clinical trials in eugene, OR

    • A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Eugene, Oregon 97401
    Sarcoma, Soft Tissue
    Study of YM155 in Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Subjects

    Eugene, Oregon
    Lymphoma, Large-Cell, Diffuse, Lymphoma, B-Cell Refractory
    AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy
    Willamette Valley Cancer Center (Main)
    Eugene, Oregon 97401-8122
    Small Cell Lung Cancer
    Study to Evaluate Erlotinib With or Without SNDX-275 in the Treatment of Patients With Advanced NSCLC
    Oncololgy Associates of Oregon
    Eugene, Oregon
    Non-Small-Cell Lung Carcinoma, Carcinoma, Non-Small Cell Lung
    Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer
    Pfizer Investigational Site
    Eugene, Oregon 97401
    Colorectal Neoplasms
    Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
    BioSante Site #106

    Trial Locations
    BioSante Site #106
    BioSante Site #050
    Hypoactive Sexual Desire Disorder
    Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine
    Oregon Research Institute
    Eugene, Oregon 97403
    Tobacco Use Disorder
    Platinum Resistant Ovarian Cancer Evaluation of Doxil and EC145 Combination Therapy
    Williamette Valley Cancer Center
    Eugene, Oregon 97401
    Ovarian Cancer
    Follow-Up Study for Exubera
    Pfizer Investigational Site
    Eugene, Oregon 97401
    Diabetes Mellitus
    Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts
    Clinical Trials of America
    Eugene, Oregon 97401
    Genital Warts
    Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids
    Clinical Trials of America
    Eugene, Oregon 97401
    Uterine Fibroids
    A Study for Patients With Relapsed Cutaneous T-Cell Lymphoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Eugene, Oregon 97401
    Cutaneous T-Cell Lymphoma
    Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma
    Willamette Valley Cancer Institute/Research Ctr
    Eugene, Oregon 97401
    B-Cell Lymphoma, B-Cell Leukemia
    A Study of LY573636 in Patients With Metastatic Breast Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Eugene, Oregon 97401
    Breast Cancer
    Nicotine Lozenge or Tobacco-Free Snuff for Smokeless Tobacco Reduction
    Oregon Research Institute
    Eugene, Oregon 97403
    Tobacco Dependence
    Novel Determinants and Measures of Smokeless Tobacco Use: Study 2
    Oregon Research Institute
    Eugene, Oregon 97403
    Tobacco Use Disorder, Nicotine Dependence
    Head to Head Study Epi proColon and FIT
    Clinical Trials of America, Inc.
    Eugene, Oregon 97401
    Colorectal Cancer
    Expanded Access of Cabozantinib in Medullary Thyroid Cancer

    Eugene, Oregon
    Medullary Thyroid Cancer
    A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Eugene, Oregon 97401
    Medulloblastoma, Childhood, Rhabdomyosarcoma